WO2006066268A3 - Synthetic transcription regulators - Google Patents
Synthetic transcription regulators Download PDFInfo
- Publication number
- WO2006066268A3 WO2006066268A3 PCT/US2005/046351 US2005046351W WO2006066268A3 WO 2006066268 A3 WO2006066268 A3 WO 2006066268A3 US 2005046351 W US2005046351 W US 2005046351W WO 2006066268 A3 WO2006066268 A3 WO 2006066268A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- synthetic transcription
- transcription regulators
- methods
- transcription
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
- C07K2319/81—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor containing a Zn-finger domain for DNA binding
Landscapes
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63661204P | 2004-12-17 | 2004-12-17 | |
| US60/636,612 | 2004-12-17 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2006066268A2 WO2006066268A2 (en) | 2006-06-22 |
| WO2006066268A3 true WO2006066268A3 (en) | 2007-02-01 |
Family
ID=36588669
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2005/046351 Ceased WO2006066268A2 (en) | 2004-12-17 | 2005-12-19 | Synthetic transcription regulators |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2006066268A2 (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6015709A (en) * | 1997-08-26 | 2000-01-18 | Ariad Pharmaceuticals, Inc. | Transcriptional activators, and compositions and uses related thereto |
| US20030105045A1 (en) * | 2000-10-13 | 2003-06-05 | Crosslink Genetics Corporation | Artificial transcriptional factors and methods of use |
-
2005
- 2005-12-19 WO PCT/US2005/046351 patent/WO2006066268A2/en not_active Ceased
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6015709A (en) * | 1997-08-26 | 2000-01-18 | Ariad Pharmaceuticals, Inc. | Transcriptional activators, and compositions and uses related thereto |
| US20030105045A1 (en) * | 2000-10-13 | 2003-06-05 | Crosslink Genetics Corporation | Artificial transcriptional factors and methods of use |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006066268A2 (en) | 2006-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2009076676A3 (en) | Compositions and methods for producing isoprene | |
| AU2017224999B2 (en) | Use | |
| WO2006071960A3 (en) | Compositions and methods of treating cell proliferation disorders | |
| WO2005003320A3 (en) | Neuronal differentiation of stem cells | |
| WO2005097825A3 (en) | Bmp-7 variants with improved properties | |
| WO2007136707A3 (en) | Methods and compositions related to eosinophil regulation | |
| PL2602323T3 (en) | Compositions and methods for inhibiting endogenous immunoglobin genes and producing transgenic human idiotype antibodies | |
| WO2003093441A3 (en) | A method of regulating gene expression | |
| NZ610633A (en) | Hydroxylated and methoxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors | |
| WO2009061381A3 (en) | Alpha-amylase variants with altered properties | |
| WO2007025097A3 (en) | Use | |
| WO2008133938A3 (en) | Targeted integration into the ppp1r12c locus | |
| WO2007041511A3 (en) | Hematopoietic progenitor kinase 1 for modulation of an immune response | |
| AU2003288686A1 (en) | Compositions and systems for the regulation of genes | |
| WO2009035547A3 (en) | Compositions and related methods for modulating alkaloid production by controlling pmt promoter activation mediated by transcriptional factors erf and myc | |
| WO2008066630A3 (en) | Methods for reprogramming adult somatic cells and uses thereof | |
| WO2009108217A3 (en) | Compositions comprising k-ras sirna and methods of use | |
| WO2009111586A3 (en) | Autonomous in vitro evolution | |
| PL2141173T3 (en) | Methods and compositions for the inhibition of gene expression | |
| WO2008150537A3 (en) | Silica particles and methods of making and using the same | |
| WO2008131258A3 (en) | Pactamycin biosynthetic gene cluster | |
| WO2008143637A3 (en) | Compositions and methods for making therapies delivered by viral vectors reversible for safety or allele-specificity | |
| WO2006019881A3 (en) | Compositions and methods for controlling biofilms and bacterial infections | |
| WO2006066268A3 (en) | Synthetic transcription regulators | |
| WO2014066392A3 (en) | Compositions and methods for regulating arterial tone |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KN KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 05854983 Country of ref document: EP Kind code of ref document: A2 |